RSLS News and Press, ReShape Lifesciences Inc. From 05/15/23

2023-05-15 19:14:12 ET ReShape Lifesciences Inc. (RSLS) Q1 2023 Earnings Conference Call May 15, 2023, 04:30 PM ET Company Participants Michael Miller - Rx Communications, IR Paul Hickey - President and CEO Tom Stankovich - CFO Conference Call Participants ...

Achieved Continued Improvement in Operational Effectiveness With First Quarter 2023 Operating Expenses Down 42.9% Compared to the First Quarter of 2022 Executing a Plan For Growth and Profitability With a Balance Sheet Bolstered By Approximately $12.7 Million Raised in 2023 Conf...

SAN CLEMENTE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will report its financial results for the first quarter ended March 31, 2023, includin...

2023-04-29 13:12:02 ET ReShape Lifesciences Inc. (RSLS) Q4 2022 Earnings Conference Call April 25, 2023 4:30 PM ET Company Participants Michael Miller - Investor Relations Paul Hickey - President & Chief Executive Officer Thomas Stankovich - Chief Financial O...

SAN CLEMENTE, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences ™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced it will present data on its proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN...

2023-04-25 16:54:28 ET ReShape Lifesciences press release ( NASDAQ: RSLS ): FY Revenue of $11.24M (-17.9% Y/Y) misses by $2.24M . Net loss of $46.21M For further details see: ReShape Lifesciences reports FY results

Continued Sequential Quarterly Growth in the U.S. With Q4 Revenues of $2.7 Million Improved Operational Effectiveness With Second Half 2022 Operating Expenses Down 27.9% Compared to the First Half of 2022, A $5.1 Million Reduction Executing A Plan For Profitability With A Balanc...

2023-04-20 09:35:28 ET ReShape Lifesciences ( NASDAQ: RSLS ) shares dipped 9% on Thursday after the health solutions company priced an offering to raise $2.5M in gross proceeds. The firm entered into a securities purchase agreement with a single institutional investor ...

SAN CLEMENTE, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchas...

2023-04-12 10:03:10 ET Gainers: Altamira Therapeutics ( CYTO ) +74% . Arrowhead Pharmaceuticals ( ARWR ) +11% . Procaps Group ( PROC ) +11% . Tempest Therapeutics ( TPST ) +11% . Meihua International Medical Technologies ( MHUA )...